As of 2026-03-24, the EV/EBITDA ratio of Abbvie Inc (ABBV) is 13.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Abbvie's latest enterprise value is 424,618.06 mil USD. Abbvie's TTM EBITDA according to its financial statements is 30,661.00 mil USD. Dividing these 2 quantities gives us the above Abbvie EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 11.6x | 10.6x |
| Forward P/E multiples | 11.7x - 17.0x | 14.4x |
| Fair Price | 41.72 - 166.28 | 104.47 |
| Upside | -79.6% - -18.9% | -49.0% |
| Date | EV/EBITDA |
| 2026-03-23 | 13.85 |
| 2026-03-20 | 13.86 |
| 2026-03-19 | 13.92 |
| 2026-03-18 | 14.05 |
| 2026-03-17 | 14.70 |
| 2026-03-16 | 14.80 |
| 2026-03-13 | 14.70 |
| 2026-03-12 | 15.03 |
| 2026-03-11 | 15.16 |
| 2026-03-10 | 15.12 |
| 2026-03-09 | 15.15 |
| 2026-03-06 | 15.30 |
| 2026-03-05 | 15.43 |
| 2026-03-04 | 15.65 |
| 2026-03-03 | 15.52 |
| 2026-03-02 | 15.54 |
| 2026-02-27 | 15.41 |
| 2026-02-26 | 14.99 |
| 2026-02-25 | 15.12 |
| 2026-02-24 | 15.20 |
| 2026-02-23 | 15.26 |
| 2026-02-20 | 15.00 |
| 2026-02-19 | 14.97 |
| 2026-02-18 | 15.22 |
| 2026-02-17 | 15.46 |
| 2026-02-13 | 15.38 |
| 2026-02-12 | 15.15 |
| 2026-02-11 | 14.77 |
| 2026-02-10 | 14.86 |
| 2026-02-09 | 14.91 |
| 2026-02-06 | 14.92 |
| 2026-02-05 | 14.66 |
| 2026-02-04 | 14.55 |
| 2026-02-03 | 15.04 |
| 2026-02-02 | 15.04 |
| 2026-01-30 | 14.89 |
| 2026-01-29 | 14.74 |
| 2026-01-28 | 14.64 |
| 2026-01-27 | 14.94 |
| 2026-01-26 | 14.76 |
| 2026-01-23 | 14.68 |
| 2026-01-22 | 14.61 |
| 2026-01-21 | 14.50 |
| 2026-01-20 | 14.37 |
| 2026-01-16 | 14.39 |
| 2026-01-15 | 14.53 |
| 2026-01-14 | 14.83 |
| 2026-01-13 | 14.76 |
| 2026-01-12 | 14.72 |
| 2026-01-09 | 14.72 |